Drug Type Small molecule drug |
Synonyms CCG-232964 |
Target |
Action inhibitors |
Mechanism MRTFB inhibitors(myocardin related transcription factor B inhibitors), RHO inhibitors(Rhodopsin inhibitors), SRF inhibitors(Serum response factor inhibitors) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H15ClN2O3S |
InChIKeyAKQOOCVXRXDGNN-UHFFFAOYSA-N |
CAS Registry2349373-70-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Scleroderma, Systemic | Preclinical | United States | 18 Apr 2019 |